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Abstract
Background: Th2-dominated inflammatory response in the airway is an integral component in the pathogenesis of allergic
asthma. Accumulating evidence supports the notion that the phosphoinositide 3-kinase (PI3K) pathway is involved in the
process. We previously reported that SHIP-1, a negative regulator of the PI3K pathway, is essential in maintaining lung
immunohomeostasis, potentially through regulation of innate immune cells. However, the function of SHIP-1 in adaptive
immune response in the lung has not been defined. We sought to determine the role of SHIP-1 in adaptive immunity in
response to aeroallergen stimulation in the airway.
Methodology/Principal Findings: SHIP-1 knockout (SHIP-1
2/2) mice on BALB/c background were immunized with
ovalbumin (OVA) plus aluminum hydroxide, a strong Th2-inducing immunization, and challenged with OVA. Airway and
lung inflammation, immunoglobulin response, Th2 cytokine production and lymphocyte response were analyzed and
compared with wild type mice. Even though there was mild spontaneous inflammation in the lung at baseline, SHIP-1
2/2
mice showed altered responses, including less cell infiltration around the airways but more in the parenchyma, less mucus
production, decreased Th2 cytokine production, and diminished serum OVA-specific IgE, IgG1, but not IgG2a. Naı ¨ve and
OVA sensitized SHIP-1
2/2 T cells produced a lower amount of IL-4. In vitro differentiated SHIP-1
2/2 Th2 cells produced less
IL-4 compared to wild type Th2 cells upon T cell receptor stimulation.
Conclusions/Significance: These findings indicate that, in contrast to its role as a negative regulator in the innate immune
cells, SHIP-1 acts as a positive regulator in Th2 cells in the adaptive immune response to aeroallergen. Thus any potential
manipulation of SHIP-1 activity should be adjusted according to the specific immune response.
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Introduction
Asthma is a chronic inflammatory disorder of the lung with
reversible airway obstruction, airway hyperresponsiveness, mucus
hyperplasia, and airway remodeling [1,2]. Th2 cytokines IL-4 and
IL-13 and the STAT6 signaling pathway play a critical role in the
pathogenesis of asthma. However, recent evidence has pointed to
the phosphoinositide 3-kinase (PI3K) signaling as another
important pathway in the generation of the asthma phenotype.
PI3K and its downstream signaling molecules such as Akt are
critical in a variety of biological processes, including cell
proliferation, survival, and migration. PI3K is critical in T cell
activation and survival [3]. The PI3K pathway is activated after
allergen challenge in sensitized mice and expression of a
dominant-negative PI3K subunit or use of PI3K inhibitors
ameliorate the inflammatory response to allergen [4,5,6].
Upon activation, PI3K phosphorylates phosphatidylinositol
(4,5) bisphosphate (PI(4,5)P2) to PI(3,4,5)P3, which is the main
lipid second messenger for downstream signaling. The intracellu-
lar levels of PI(3,4,5)P3 are regulated by two phosphatases, tensin
homologue deleted on chromosome ten (PTEN) and Src
homology region 2 domain-containing inositol 59-phosphatase-1
(SHIP-1). SHIP-1 dephosphorylates PI(3,4,5)P3 to generate
PI(3,4)P2 [7,8]. SHIP-1 is believed to be a negative regulator in
a variety of cytokine, immunoreceptor, and growth factor signaling
pathways in different cell types, including T cells, B cells, mast
cells, basophils, and neutrophils [8,9,10,11,12,13,14]. SHIP-1
deficiency as in gene-targeted deletion resulted in spontaneous
inflammatory cell infiltration in the lung of some mice [11,12],
which has been recently identified by our group as a Th2-like
allergic inflammatory phenotype that may be related to enhanced
mast cell response [15]. Adoptively transferred SHIP-1 deficient
mast cells were shown to enhance allergic and anaphylactic
responses in vivo [16]. In T cells, SHIP-1 was reported to regulate
cytokine activation in a way favoring Th2 response but limiting
Th1 cytotoxicity [17]. However, a regulatory role of SHIP-1 in
adaptive immune response to allergen stimulation in the airway
has not been established.
In this study, we examined the role of SHIP-1 in Th2 cell
activation, Th2 cytokine production and allergic inflammation in
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14174the lung in response to allergen stimulation using SHIP-1 null
mice in an allergic asthma model. Our results show that in the
absence of SHIP-1 Th2-dominated allergic inflammatory respons-
es to ovalbumin are impaired, suggesting a critical role of SHIP-1
in adaptive Th2 immune response to aeroallergen.
Results
Airway inflammatory responses to allergen in SHIP-1
2/2
mice
To assess lung inflammatory responses to aeroallergen we
determined the total and differential cell counts in the BAL fluid
24 hr after last OVA challenge (day 16). At age of 6–8 weeks, WT
mice in PBS control group had baseline total cell counts in the
BAL but SHIP-1
2/2 mice received PBS had slightly but
significantly increased total cell counts in the BAL (Figure 1A),
indicating mild spontaneous inflammation in the lung. This was
consistent with our previous report on SHIP-1
2/2 mice that
develop spontaneous inflammation in the lung [15], although
BALB/c SHIP-1
2/2 mice have a relatively milder phenotype.
After OVA challenge, as expected, WT mice had significantly
increased BAL cell counts compared to the PBS group. SHIP-1
2/2
mice also had increased BAL cell counts but, unexpectedly, not
more than that of WT-OVA mice (Figure 1A). Differential cell
counts showed that after OVA challenge WT mice had increased
eosinophils in the airways as expected in this model. However,
SHIP-1
2/2 mice had significantly less eosinophils compared to
WT-OVA mice, even though the number was higher than the
baseline (Figure 1B). Similar trend was seen in the numbers of
neutrophils and lymphocytes but the difference between WT mice
and SHIP-1
2/2 mice was not statistically significant.
Lung histology
Lung histology revealed that in PBS groups, WT mice had no
inflammatory cell infiltration in the lung but SHIP-1
2/2 mice had
some cell infiltration with small clusters of cells at the vicinity of the
bronchovascular bundles in the lung (Figure 1C). With OVA
challenge, WT mice had a usual pulmonary inflammatory
response with cellular infiltration surrounding the airways and
vasculatures, similar to peribronchial cuffing. Most cells were
eosinophils and mononuclear cells. However, with OVA challenge
SHIP-1
2/2 mice only showed a modest increase in cell infiltration
in the lung and the pattern of distribution of the cells was different
from that of WT mice, as most of the cells were in the lung
parenchyma with some close to but not surrounding the airways
(Figure 1C). Mucus hyperplasia is a characteristic Th2 response
to allergen stimulation. We asked if SHIP-1
2/2 mice had altered
mucus response. Alcian blue stained lung sections revealed that
without OVA stimulation no mucin-producing cells were found in
the lung of WT or SHIP-1
2/2 mice. After OVA challenge WT
mice had a robust mucus response with a significant number of
goblet cells in the airways while SHIP-1
2/2 mice only had a
minimal response (Figure 2A). Quantitative measurement of
Alcian blue positive cells in the airways demonstrated that SHIP-
1
2/2 mice had significantly fewer mucin producing cells than WT
mice in response to OVA (Figure 2B).
OVA-specific IgE, IgG1 and IgG2a production
We reported previously that SHIP-1
2/2 mice had increased
total IgE levels in the lung [15]. In this study we examined the
allergen induced immunoglobulin response by measuring serum
levels of OVA-specific IgE, IgG1 and IgG2a. Significant amount
of antigen-specific IgE was detected in the serum samples from
WT mice after OVA challenge. However, SHIP-1
2/2 mice with
OVA challenge had only background levels of OVA-specific IgE
in the serum (Figure 3A). Even though OVA-specific IgG1
production in SHIP-1
2/2 mice after OVA stimulation was higher
than that at the baseline, the level was still significantly lower than
that of WT mice (Figure 3B). These results indicate an impaired
antibody specific response to allergen in the SHIP-1
2/2 mice.
After OVA challenge neither WT mice nor SHIP-1
2/2 mice
showed any change in the serum levels of IgG2a, which is usually
involved in Th1 responses (Figure 3C).
Figure 1. Allergic inflammatory response in the airways. WT and
SHIP-1
2/2 mice were sensitized with OVA allergen and challenged with
PBS (OVA/PBS) or OVA (OVA/OVA) as described in Methods. Total and
differential cell counts in the BAL fluid were determined. (A) BAL total
cell counts. (B) BAL differential cell counts. Data expressed as
Mean6SEM were from a representative experiment (n=4–6 mice each
group; *p,0.05). (C) Lung histology, H&E staining (20x), with an arrow
indicating inflammatory cell infiltration.
doi:10.1371/journal.pone.0014174.g001
SHIP-1 in Lung Inflammation
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Next we examined the cytokine response to OVA allergen
challenge in the airway. WT mice and SHIP-1
2/2 mice treated
with PBS showed only background levels of Th2 cytokines IL-4,
IL-5, and IL-13 and Th1 cytokine IFN-c in the BAL. WT mice
challenged with OVA showed significant increases in Th2
cytokines. In contrast, SHIP-1
2/2 mice challenged with OVA
did not show any increase in IL-4, IL-5, or IL-13 in the BAL
above the baseline. Although OVA challenged SHIP-1
2/2 mice
had a significant increase in the IFN-c levels compared to the PBS
control group and less increased IFN-c in SHIP-1
2/2-OVA
group, the difference between WT and SHIP-1
2/2 OVA groups
was not significant (Figure 4).
Reduced IL-4 production by sensitized SHIP-1
2/2 splenic
cells
We next examined whether in vivo sensitized SHIP-1
2/2
lymphocytes had a different pattern of IL-4 production relative to
that of WT mice in response to OVA stimulation. Splenocytes in
single-cellsuspensionfromOVAsensitized andchallenged mice were
stimulated with OVA for 3 days and IL-4 in the culture supernatant
was assayed. WT splenocytes responded to OVA normally and
produced a significant amount of IL-4. In contrast, SHIP-1
2/2
splenocytes produced markedly lower levels of IL-4 (Figure 5). This
result is consistent with the observation of diminished Th2 cytokine
production in the lung and suggests a defect in Th2 celldifferentiation
and/or Th2 cytokine production in SHIP-1
2/2 mice.
Figure 2. Lung histology and quantitative assessment of mucus metaplasia. (A) Alcian blue staining (20x) of lung sections. (B) Percentage of
Alcian blue positive cells in the airways. Epithelial cells, 100–200/each airway, were counted and the percentage of Alcian blue positive cells was
determined (n=3–4/group).
doi:10.1371/journal.pone.0014174.g002
SHIP-1 in Lung Inflammation
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To further identify the cell types that were defective in response
to allergen stimulation we tested T cells and APC in separate ex-
periments. Splenic T cells from unsensitized WT and SHIP-1
2/2
mice were prepared and activation of TCR via plate-coated a-
CD3 with or without soluble a-CD28 for 72 hr was performed.
SHIP-1
2/2 T cells produced significantly lower amount of IL-4
compared with WT T cells (Figure 6A). These results suggest that
the number of T cells able to produce IL-4 and/or the TCR
signaling for IL-4 production in SHIP-1
2/2 mice was decreased as
compared to that of WT mice. Isolated T cells from WT and
SHIP-1
2/2 mice were then incubated with irradiated splenic APC
from either WT or SHIP-1
2/2 mice in the presence of OVA
peptide323–339. Again, T cells from SHIP-1
2/2 mice did not
respond well to either WT APC or SHIP-1
2/2 APC. Interestingly,
WT T cells produced more IL-4 when incubated with APC from
SHIP-1
2/2 mice (Figure 6B). These results indicate that SHIP-
1
2/2 T cells had impaired response to antigen stimulation while
SHIP-1
2/2 APC had enhanced activity in the presence of antigen.
Figure 3. Serum levels of OVA-specific immunoglobulins. Serum samples of WT and SHIP-1
2/2 mice were collected at the time of sacrifice
and OVA allergen-specific IgE, IgG1 and IgG2a were measured by ELISA. (A) Serum OVA-specific IgE. (B) Serum OVA-specific IgG1 and (C) Serum OVA-
specific IgG2a (n=4–6 mice each group; *p,0.05 and **p,0.01).
doi:10.1371/journal.pone.0014174.g003
Figure 4. Inflammatory cytokines in the BAL fluid. After sensitization with OVA and challenged with OVA or PBS control, BAL fluid was
obtained and cytokines in the BAL were measured using ELISA kits. Data were Mean6SEM (NS, not significant; *p,0.05; **p,0.01. n=4–6 mice each
group).
doi:10.1371/journal.pone.0014174.g004
SHIP-1 in Lung Inflammation
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The above results indicate that T cells from SHIP-1
2/2 mice
undergoing Th2 differentiation in vivo had suppressed IL-4
production. To verify whether this is differentiation related we
performed in vitro Th2 differentiation experiments. Splenic T cells
from naı ¨ve mice were incubated under the Th2-polarizing
condition and T cell production of IL-4 and IFN-c was
determined after the cells were re-stimulated with medium control,
a-CD3 or a-CD3/a-CD28. Without TCR stimulation undiffer-
entiated Th0 cells and differentiated Th2 cells from WT and
SHIP-1
2/2 mice did not produce any detectable levels of IL-4 or
IFN-c (Figure 7). With TCR stimulation WT Th0 cells produced
a considerable amount of IL-4 that was further increased by
differentiated Th2 cells. In contrast, both SHIP-1
2/2 Th0 and
Th2 cells produced significantly lower amounts of IL-4 compared
to those of WT cells (Figure 7). On the other hand, the opposite
was observed in IFN-c production in that SHIP-1
2/2 Th0 and
Th2 cells produced increased IFN-c than those of WT cells
(Figure 7). These studies indicate that SHIP-1
2/2 Th0 cells can
differentiate into Th2 cells but to a suboptimal degree and SHIP-1
is critical for T cell IL-4 production and is a negative regulator in
IFN-c production.
Discussion
Several studies showed that the PI3 kinase signaling pathway,
particularly the PI3Kd and PI3Kc isoforms, plays an important
role in the pathogenesis of allergen induced inflammatory response
[4,5,6,18,19]. SHIP-1 regulates PI3 kinase signaling by dephos-
phorylating intracellular PIP3. SHIP-1 functions in a variety of cell
types, including T cells and mast cells. SHIP-1 knockout mice at
age 9-11 weeks developed a spontaneous Th2-like allergic
inflammatory response in the lung that may involve innate
immune cells [15]. In contrast, conditional deletion of SHIP-1 in
T cells resulted in reduced Th2 responses to nitrophenylacetyl
hapten conjugated to chicken c globulin (NP-CGG) or to
Schistosoma eggs [17]. The reason for these seemingly contradictory
results is unknown. A possible explanation is that SHIP-1 has
divergent roles in different innate and adaptive immune cells. A
potential role of SHIP-1 in Th2 adaptive immune responses to
aeroallergen stimulation has not been defined. In this study, we
examined the role of SHIP-1 in adaptive immune response using
SHIP-1 null mice in an allergic asthma model.
Upon OVA allergen challenge, sensitized WT mice displayed
robust allergic inflammatory responses, including macrophage and
eosinophil dominated cell infiltration in the airway and in the lung
parenchyma, goblet cell hyperplasia, OVA-specific IgE and IgG1
production, and Th2 cytokine production in the lung. In contrast,
in response to OVA challenge, sensitized SHIP-1
2/2 mice showed
similar or lower cell counts in the BAL, less infiltration in the lung
tissue, less mucus production, no OVA-specific IgE and lower
IgG1 in the serum, and no increased production of Th2 cytokines,
IL-4, IL-5, and IL-13 in the lung. These results were surprising in
that SHIP-1
2/2 mice on C57BL/6x129sv mixed background
developed spontaneous Th2-like inflammation in the lung as
described in our previous study [15] and SHIP-1
2/2 mice on
BALB/c background at age 6–8 weeks showed mild but detectable
cell infiltration in the airway in the present study. However, these
two studies were set to answer different questions about the
functions of SHIP-1. One is concerning spontaneous Th2-like
inflammation without exposure to known allergens with the
possibility of involving mast cells or basophils that are able to
produce Th2 cytokines. Another is to examine the role of SHIP-1
in the adaptive immune response in an allergic inflammation
model induced by OVA allergen. The latter was carried out in
younger mice on BALB/c background, which are usually more
prone to Th2 immunity, to test T cell and B cell responses.
Indeed, our experiments testing T cell responses showed that
SHIP-1
2/2 splenocytes isolated from OVA sensitized and
challenged mice were much less responsive to OVA antigen
stimulation in IL-4 production compared to WT cells. Further-
more, isolated naive SHIP-1
2/2 T cells were less responsive to
TCR stimulation, although SHIP-1
2/2 APC might have
increased activity. These results suggest that either the develop-
ment of Th2 cell population in SHIP-1
2/2 mice is retarded or the
IL-4 producing capacity of SHIP-1
2/2 T cells is decreased. The
mechanism for enhanced APC activity in SHIP-1 deficient cells is
under investigation.
Further in vitro differentiation studies demonstrated that
compared to WT cells, undifferentiated SHIP-1
2/2 Th0 cells
produced significantly less IL-4 and these cells could be polarized
to Th2 cells but to a limited degree. These findings indicate that
SHIP-1 is essential for optimal Th2 development and response to
antigen stimulation. Interestingly, IFN-c production in SHIP-1
2/2
T cells was significantly increased under both Th0 and Th2
conditions (Figure7).This isconsistent with the findings reported by
Tarasenko et al. suggesting that SHIP-1 may have inhibitory effect
on IFN-c production [17]. On the other hand, this data seems to be
different from our in vivo findings that the level of BAL IFN-c of
SHIP-1
2/2 mice had a trend of reduction compared to WT mice.
Although IFN-c is not a reliable cytokine in OVA induced Th2
responses, a possible explanation is that the in vivo finding is a result
of impaired T cell response, involving both IFN-c and Th2
cytokines.
The finding that the level of OVA-specific IgE in SHIP-1
2/2
mice was diminished seems in contrast with our previous
observation of increased total serum IgE in the SHIP-1
2/2 mice
on the mixed background. The reason for the difference is not
known. In addition, the reduced OVA-specific IgE production
may have some parallels in a previous study in which inhibition of
p110d PI3 kinase genetically or pharmacologically enhanced IgE
production after OVA allergen immunization [20]. This is
Figure 5. IL-4 production by sensitized splenocytes. Splenocytes
were isolated from OVA sensitized and challenged WT and SHIP-1
2/2
mice. After OVA allergen stimulation, IL-4 levels in the culture
supernatant were determined (n=6 mice for each group).
doi:10.1371/journal.pone.0014174.g005
SHIP-1 in Lung Inflammation
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production and allergic inflammatory response was significantly
reduced in p110d null mice or in the presence of a p110d inhibitor
[5,18]. The former study and ours indicate that the intracellular
levels of PIP3 are important in regulating IgE production in
response to allergen stimulation.
Our findings of an incomplete Th2 response to aeroallergen
stimulation in SHIP-1
2/2 mice are consistent with those in an
earlier report using a different approach in different models [17].
In that study, Tarasenko et al. reported that SHIP-1 deficient T
cells did not skew efficiently to Th2 in vitro and mice with these
SHIP-1 deficient T cells showed either poor antibody response to
NP-CGG immunization or diminished Th2 cytokine production
in response to Schistosoma parasite challenge [17]. Together, this
study and ours indicate that SHIP-1 is critical in Th2 development
in adaptive immune response to different stimuli.
In a recent study, adoptive transfer of bone marrow-derived
mast cells from SHIP-1
2/2 mice enhanced OVA allergen induced
inflammatory response in mast cell deficient recipients [16]. In
that system, T cells, B cells, and APC in the adaptive immune
system still have intact SHIP-1 function and can mount an efficient
Th2 immune response. Thus in this case, SHIP-1 deficient mast
cells contribute to the process as effector cells that amplify the Th2
response. This is in accordance with our previous study [15] and is
Figure 6. Response of naı ¨ve T cells to stimulation. (A) CD4+ T cells isolated from unsensitized WT and SHIP-1
2/2 mice were incubated with
medium, a-CD3, or a-CD3/a-CD28 for 24 hr and the levels of IL-4 in the culture medium were determined by ELISA (n=5 each group, ***p,0.001). (B)
Naı ¨ve CD4+ T cells isolated from WT and SHIP-1
2/2 mice were incubated with negatively selected, irradiated APC from the spleen of WT or SHIP-1
2/2
mice in different ratios in the presence of OVA323–339 and IL-4 production was determined (n=4 for each group).
doi:10.1371/journal.pone.0014174.g006
SHIP-1 in Lung Inflammation
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SHIP-1 deficient T cells [17].
Taken together, our studies on spontaneous inflammation in the
lung and on adaptive immune responses to allergen stimulation in
SHIP-1 deficient mice demonstrate that SHIP-1 plays divergent
roles in mast cells and T cells in innate and adaptive immune
responses, respectively, under different circumstances. Thus
caution should be taken in the development of regimens targeting
SHIP-1. Non-specific promotion or suppression of SHIP-1 activity
may not achieve the desired outcome of treating Th2 dominated
diseases such as allergy, anaphylaxis and asthma. Instead, cell-
specific approach at different stages should be considered.
Materials and Methods
Animals
The SHIP-1
2/2 mice were generated as previously described
[10]. We reported in a previous study that SHIP-1
2/2 mice on a
C57BL/6x129Sv mixed genetic background developed spontane-
ous and progressive Th2-like allergic inflammatory responses in
the lung [15]. SHIP-1
2/2 mice on BALB/c genetic background
develop similar but milder inflammatory responses in the lung with
slower disease progression. In this study 6–8 week old SHIP-1
2/2
mice on BALB/c genetic background (backcrossed more than 10
generations from the original knockout mice) were used. In all
experiments, SHIP-1
2/2 mice were compared with age-matched
wild type (WT or SHIP-1
+/+) mice. Mice were maintained in a
specific pathogen-free facility. All experimental protocols involving
mice were approved by the Johns Hopkins University Institutional
Animal Use and Care Committee.
OVA allergen immunization and challenge
Mice were immunized by intraperitoneal (i.p.) injection of 75 mg
ovalbumin (OVA) mixed with 1 mg aluminum hydroxide (Alum)
(Sigma-Aldrich, St. Louis, MO) in a volume of 200 mL on days 0
and 7 and challenged by intranasal (i.n.) instillation of 20 mg OVA
in 20 ml PBS (OVA/OVA group) or PBS alone (OVA/PBS group)
under anesthesia on days 14 and 15. Prior to application, OVA
preparation was depleted of endotoxin by passing through Detoxi-
Gel columns (Pierce, Rockford, IL). On day 16 mice were
sacrificed and bronchoalveolar lavage (BAL) fluid was collected in
360.7 ml PBS as previously described [21]. Total cell counts in
the BAL fluid were determined using a Neubauer hemocytometer.
BAL cell differentials (200 counts/slide) were determined after
centrifugation of 1610
5 cells in Cytospin II (Thermo Shandon,
Pittsburgh, PA). Supernatants from the BAL samples were kept at
270uC for later cytokine measurement.
Lung histology and quantitative assessment of mucus
hyperplasia
After obtaining the BAL samples, the lungs were perfused and
then removed en bloc and inflated with and fixed in 10% buffered
formalin (Sigma-Aldrich) overnight before being processed and
embedded in paraffin as described previously [21]. Embedded
lungs were sectioned at 5 mm thickness and stained with H&E and
Alcian blue for evaluation of lung tissue inflammation and airway
mucous metaplasia, respectively [22]. Quantitative assessment of
mucus hyperplasia was performed by counting Alcian blue positive
cells in the epithelia of 5–7 middle-sized airways of each sample.
The percentage of Alcian blue positive cells/total epithelial cells
was calculated.
Preparation of CD4+ T cells, antigen presenting cells
(APC), and stimulation of T cells
Splenic CD4+ T cells were isolated through negative selection
using the CD4 T lymphocyte enrichment IMag set (BD Pharmin-
gen,SanDiego,CA).ThepurityoftheT cellswasgreaterthan 92%
by flow cytometry analysis. To isolate APC, splenocytes were
depleted of CD4+ and CD8+ cells using an IMag set (BD
Pharmingen). T cell-depleted APCs were then irradiated with
3500 rad before the co-culture experiments. OVA peptide 323–339
(OVA323–339)( 5mg/ml) was added to the T cell culture in the
presence of APCs [23]. The ratio of T cell to APC was 1:1 or 1:2. In
other experiments, purified T cells (1610
5/well) were incubated for
3 days withplate-bound anti-CD3 (10 mg/ml, BD Pharmingen) and
soluble anti-CD28 (2 mg/ml, eBioscience, San Diego, CA).
Cytokines in the culture supernatant were measured by ELISA.
To induce Th2 differentiation, T cells were isolated from spleen
and incubated (1610
6/well) with Th2 differentiation cocktail: IL-4
(15 ng/ml, R&D Systems, Minneapolis, MN), anti-IL-12 mAb
(15 mg/ml, clone C17.8, BD Pharmingen), and anti-IFN-c mAb
(15 mg/mL, clone XMG1.2, BD Pharmingen). After 72 hr the cells
were washed 3 times, cultured in medium containing IL-2 (10 ng/
ml) for another 3 days. After washing 3 times, the cells were re-
stimulated with a-CD3, a-CD3/a-CD28, or medium control for
24 hr and cytokines in the supernatant were measured by ELISA.
OVA-specific IgE, IgG1 and IgG2a
Serum levels of OVA-specific IgE, IgG1 and IgG2a were
determined by ELISA. Briefly, plates were pre-coated overnight at
Figure 7. Cytokine response of Th0 and in vitro differentiated
Th2 cells. CD4+ T cells were isolated from spleen of WT and SHIP-1
2/2
mice and cultured (1610
6/well) under Th0 or Th2 polarizing conditions
for 3 days. After further expanding in IL-2 for another 3 days, the cells
were re-stimulated with a-CD3 or a-CD3/a-CD28 for 24 hr. IFN-c and IL-
4 levels in the culture supernatant were determined by ELISA. The
results are shown as Mean6SEM of triplicate samples of pooled cells
from 2 mice per group. The same experiment was repeated two more
times with similar results (N.D.=not detected; *p,0.05; **p,0.01).
doi:10.1371/journal.pone.0014174.g007
SHIP-1 in Lung Inflammation
PLoS ONE | www.plosone.org 8 November 2010 | Volume 5 | Issue 11 | e141744uC with 20 mg/ml OVA in PBS. After the plates were blocked
with 20% FBS, serum samples were added and incubated for 2 hr
at room temperature followed by biotinylated anti-mouse IgE,
IgG1 or IgG2a (BD Pharmingen), avidin-HRP, and tetramethyl-
benzidine substrate. The optical density of the reactions was
measured by a microplate reader at 450 nm. Purified mouse IgE
or IgG2a was used as standards (BD Pharmingen). IgG1 levels
were expressed in O.D.
Cytokine measurement
Cytokines IL-4, IL-5, IL-13, and IFN-c in the BAL or in culture
supernatant samples were determined by using commercially
available ELISA kits according to the manufacturer’s instructions
(R&D Systems or eBioscience).
Statistical analysis
Data from the experiments were analyzed by Student’s t test for
comparison between two groups or one-way analysis of variance
(ANOVA) for comparison of more than two groups. The results
were expressed as Mean6Standard Error of the Mean (SEM).
Differences between groups with P values less than 0.05 were
considered statistically significant.
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